Drug
combined oral contraceptives
combined oral contraceptives is a pharmaceutical drug with 7 clinical trials. Historical success rate of 66.7%.
Total Trials
7
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Terminated
1(14%)
Phase Distribution
Ph not_applicable
1
14%
Ph phase_2
1
14%
Ph phase_3
3
43%
Phase Distribution
0
Early Stage
1
Mid Stage
3
Late Stage
Phase Distribution5 total trials
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
3(60.0%)
N/ANon-phased studies
1(20.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
50.0%
2 of 4 finished
Non-Completion Rate
50.0%
2 ended early
Currently Active
0
trials recruiting
Total Trials
7
all time
Status Distribution
Completed(2)
Terminated(2)
Other(3)
Detailed Status
unknown3
Completed2
Withdrawn1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
7
Active
0
Success Rate
66.7%
Most Advanced
Phase 3
Trials by Phase
Phase 21 (20.0%)
Phase 33 (60.0%)
N/A1 (20.0%)
Trials by Status
withdrawn114%
completed229%
unknown343%
terminated114%
Recent Activity
0 active trials
Showing 5 of 7
unknownnot_applicable
Stopping Heavy Periods Project
NCT02002260
completed
Oral Contraceptive Hormone-free Interval Pituitary/ Ovarian Activity
NCT01953211
withdrawnphase_3
Hormone Replacement for Premature Ovarian Insufficiency
NCT02922348
completedphase_2
LNG-IUS for Treatment of Dysmenorrhea
NCT01601366
unknownphase_3
Combined Oral Contraceptives and Fluoxetine Versus Combined Oral Contraceptives in Severe Premenstrual Syndrome
NCT02488538
Clinical Trials (7)
Showing 7 of 7 trials
NCT02002260Not Applicable
Stopping Heavy Periods Project
NCT01953211
Oral Contraceptive Hormone-free Interval Pituitary/ Ovarian Activity
NCT02922348Phase 3
Hormone Replacement for Premature Ovarian Insufficiency
NCT01601366Phase 2
LNG-IUS for Treatment of Dysmenorrhea
NCT02488538Phase 3
Combined Oral Contraceptives and Fluoxetine Versus Combined Oral Contraceptives in Severe Premenstrual Syndrome
NCT02562053Phase 3
Does Adding Oral Contraceptives to Fluoxetine Improve the Management of Premenstrual Syndrome?
NCT00091728
Hormonal Contraception and Risk of Chlamydia and Gonorrhea
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7